Literature DB >> 27852960

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology.

Ido Hartogsohn1.   

Abstract

Placebo response theory and set and setting theory are two fields which examine how non-biological factors shape the response to therapy. Both consider factors such as expectancy, preparation and beliefs to be crucial for understanding the extra-pharmacological processes which shape the response to drugs. Yet there are also fundamental differences between the two theories. Set and setting concerns itself with response to psychoactive drugs only; placebo theory relates to all therapeutic interventions. Placebo theory is aimed at medical professionals; set and setting theory is aimed at professionals and drug users alike. Placebo theory is primarily descriptive, describing how placebo acts; set and setting theory is primarily prescriptive, educating therapists and users on how to control and optimize the effects of drugs. This paper examines how placebo theory and set and setting theory can complement and benefit each other, broadening our understanding of how non-biological factors shape response to drugs and other treatment interventions.
© The Author(s) 2016.

Keywords:  Placebo; expectancy; hallucinogens; non-drug factors; psychedelics; set and setting; social pharmacology

Mesh:

Substances:

Year:  2016        PMID: 27852960     DOI: 10.1177/0269881116677852

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  67 in total

Review 1.  The acute effects of classic psychedelics on memory in humans.

Authors:  C J Healy
Journal:  Psychopharmacology (Berl)       Date:  2021-01-09       Impact factor: 4.530

Review 2.  The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Authors:  Robin L Carhart-Harris; Guy M Goodwin
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

3.  Psychedelics for psychological and existential distress in palliative and cancer care.

Authors:  D Rosenbaum; A B Boyle; A M Rosenblum; S Ziai; M R Chasen; MPhil Pall Med
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

4.  An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders.

Authors:  Marika Renelli; Jenna Fletcher; Kenneth W Tupper; Natasha Files; Anya Loizaga-Velder; Adele Lafrance
Journal:  Eat Weight Disord       Date:  2018-11-24       Impact factor: 4.652

5.  Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy.

Authors:  Justin C Strickland; Albert Garcia-Romeu; Matthew W Johnson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-29

6.  Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Authors:  Gabrielle Agin-Liebes; Trevor F Haas; Rafael Lancelotta; Malin V Uthaug; Johannes G Ramaekers; Alan K Davis
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-23

Review 7.  Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Authors:  Jacob S Aday; Alan K Davis; Cayla M Mitzkovitz; Emily K Bloesch; Christopher C Davoli
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-05

8.  Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies.

Authors:  Erich Studerus; Patrick Vizeli; Samuel Harder; Laura Ley; Matthias E Liechti
Journal:  J Psychopharmacol       Date:  2021-03-30       Impact factor: 4.153

Review 9.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

10.  Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center.

Authors:  Brian Rush; Olivia Marcus; Sara García; Anja Loizaga-Velder; Gabriel Loewinger; Ariane Spitalier; Fernando Mendive
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.